It is a trading private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 | Mumbai, Maharashtra, India | ActiveDigilent Pharmaceuticals Private Limited, a active private limited company, was established on 12 July 2020 in Mumbai, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909MH2020PTC341781. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.98 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shivshankar (Director), Mansa Kumari (Director). Past directors included Santosh Singh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Nasim Ahmed Shaikh Afsarali Chawl R H No 3, Masjid Road Golibar Santacruz E, Mumbai, Maharashtra, 400055.
U51909MH2020PTC341781
341781
12 July 2020
₹0.98 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Digilent Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivshankar | Director | 12 Jul 2020 | Current |
| Mansa Kumari | Director | 26 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Digilent Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 649.34% increase. The company also saw a substantial improvement in profitability, with a 117.37% increase in profit. The company's net worth Soared by an impressive increase of 31.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Digilent Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Digilent Pharmaceuticals has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Digilent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Digilent Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mansa Kumari was appointed as a Director was appointed as a Director on 26 May 2025 & has been associated with this company since 6 months 8 days . was completed.
Progress on Digilent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Digilent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Shivshankar was appointed as a Director was appointed as a Director on 12 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
The activity Digilent Pharmaceuticals Private Limited was registered on 12 Jul 2020 with Roc Mumbai & aged 5 years 4 months as per MCA records. was completed.
The CIN of Digilent Pharmaceuticals Private Limited is U51909MH2020PTC341781.
Digilent Pharmaceuticals Private Limited is headquartered at C/O Nasim Ahmed Shaikh Afsarali Chawl R H No 3, Masjid Road Golibar Santacruz E, Mumbai, Maharashtra, 400055.
Digilent Pharmaceuticals Private Limited was incorporated on 12 July 2020.
The current directors of Digilent Pharmaceuticals Private Limited are
The primary industry of Digilent Pharmaceuticals Private Limited is Trading.
Digilent Pharmaceuticals Private Limited is unlisted.
The authorized capital of Digilent Pharmaceuticals Private Limited is ₹0.98 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX